Serum Institute of India Pvt. Ltd. (SIIPL)

Moderator Of 1 Session

Industry Sponsored Symposium 04 (a non-accredited Industry Sponsored Symposium and is NOT part of the accredited main event)

Session Type
Industry-Sponsored Symposium
Wed, 22.06.2022
Session Time
07:30 - 08:30
Grand Ballroom Centre
Session Description
Product and Clinical development of a 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) - Supported by Serum Institute of India
A new Polysaccharide Conjugate Vaccine, PNEUMOSIL® has been licensed by Government of India and prequalified by WHO. This session covers the CMC and Clinical development of this vaccine which is likely to make a very positive public health impact in MICs and LMICs.